IGRT
Showing 1 - 25 of 148
Secondary Antibody Deficiency Trial (Immunoglobulin replacement therapy (IGRT))
Not yet recruiting
- Secondary Antibody Deficiency
- Immunoglobulin replacement therapy (IGRT)
- (no location specified)
Nov 4, 2022
Artificial Intelligence in CNS Radiation Oncology
Not yet recruiting
- CNS Tumor
- The images (CT, MRI, PET) used for RT planning, mid-treatment imaging as part of IGRT or disease evaluation, and response assessment/ surveillance post-RT
- (no location specified)
Sep 6, 2023
Hematologic Malignancy Trial in New York (Linac Based VMAT TBI)
Recruiting
- Hematologic Malignancy
- Linac Based VMAT TBI
-
New York, New YorkNYU Langone Health
Jan 13, 2022
ABlative Radiotherapy (for) Unfavorable Prostate Tumors
Recruiting
- Prostate Cancer
-
Monza, MB, ItalyRadiation Oncology, ASST Monza (University of Milan Bicocca)
Jul 21, 2022
NSCLC Trial in United States (Radiation Therapy, Conventional radiation)
Active, not recruiting
- Non-small Cell Lung Cancer
- Radiation Therapy
- Conventional radiation
-
Austin, Texas
- +6 more
May 11, 2022
Prostatic Tumors Trial in Trondheim, Ålesund (radiotherapy daily verification reduced safety margins, radiotherapy weekly
Active, not recruiting
- Prostatic Neoplasms
- radiotherapy daily verification reduced safety margins
- radiotherapy weekly verification standard safety margins
-
Trondheim, Norway
- +1 more
Feb 16, 2022
Prostate Cancer Trial in Milwaukee (Radiation Therapy)
Recruiting
- Prostate Cancer
- Radiation Therapy
-
Milwaukee, WisconsinFroedtert Hospital
Mar 8, 2022
Glioma, Recurrent Glioma Trial in Shanghai (Hypofractionated Stereotactic Radiotherapy, Bevacizumab)
Active, not recruiting
- Glioma
- Recurrent Glioma
- Hypofractionated Stereotactic Radiotherapy
- Bevacizumab
-
Shanghai, Shanghai, ChinaCyberKnife Center, Department of Neurosurgery, Huashan Hospital
Nov 3, 2022
Prostate Cancer Trial in Bronx (IGRT 45 Gy in 5 fractions of 9 Gy, IGRT 24 Gy single dose, Dexamethasone)
Recruiting
- Prostate Cancer
- IGRT 45 Gy in 5 fractions of 9 Gy
- +3 more
-
Bronx, New YorkMontefiore Medical Center - Moses Campus
Aug 19, 2021
Stage IV NSCLC Trial in Palo Alto (Immunotherapy (physician's choice for standard of care immunotherapy), Image-guided Radiation
Active, not recruiting
- Stage IV Non-Small Cell Lung Cancer
- Immunotherapy (physician's choice for standard of care immunotherapy)
- Image-guided Radiation Therapy
-
Palo Alto, CaliforniaStanford University, School of Medicine
Aug 17, 2022
Prostate Cancer, Radiotherapy Side Effect, Hypofractionation Trial in Quebec (grade and compare reported side effects between
Recruiting
- Prostate Cancer
- +5 more
- grade and compare reported side effects between groups
-
Quebec, CanadaCHUdeQuebec
Mar 14, 2023
Breast Cancer Trial in New York (IGRT for prone partial breast irradiation (PBI))
Completed
- Breast Cancer
- IGRT for prone partial breast irradiation (PBI)
-
New York, New YorkLaura and Isaac Perlmutter Cancer Center at NYU
Jan 13, 2021
Prostate Cancer Trial in Navi-Mumbai (IGRT)
Active, not recruiting
- Prostate Cancer
- IGRT
-
Navi-Mumbai, Maharashtra, IndiaDr Vedang Murthy
Nov 20, 2021
Brain Metastases, Adult, Cancer Brain Trial in Switzerland (IGRT, SRS)
Recruiting
- Brain Metastases, Adult
- Cancer Brain
- IGRT
- SRS
-
Bellinzona, Ticino, Switzerland
- +5 more
Feb 9, 2022
Cancer of Head and Neck, Head Neck Cancer, Tumors, Head and Neck Trial in Boston, Saint Louis, New York (biological, procedure,
Active, not recruiting
- Cancer of Head and Neck
- +5 more
- MK-3475 (neoadjuvant)
- +6 more
-
Boston, Massachusetts
- +2 more
Dec 9, 2022
NSCLC Trial (Image-Guided Radiation Therapy)
Completed
- Non-small Cell Lung Cancer
- Image-Guided Radiation Therapy
- (no location specified)
Apr 8, 2021
NSCLC Trial in Copenhagen (BioXmark)
Completed
- Non-Small Cell Lung Cancer
- BioXmark
-
Copenhagen, DenmarkRigshospitalet, Denmark
Jan 28, 2021
Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8, Stage III Lung Cancer AJCC v8 Trial (drug,
Not yet recruiting
- Locally Advanced Lung Non-Small Cell Carcinoma
- +2 more
- Carboplatin
- +11 more
- (no location specified)
Nov 14, 2022
Recurrent Lung Non-Small Cell Carcinoma, Stage II NSCLC AJCC v7, Stage IIA Non-Small Cell Lung Carcinoma AJCC v7 Trial in
Recruiting
- Recurrent Lung Non-Small Cell Carcinoma
- +5 more
- Image Guided Radiation Therapy
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jun 15, 2021
Lung Cancer Trial in Stanford, Dallas (hypofractionated radiation therapy)
Completed
- Lung Cancer
- hypofractionated radiation therapy
-
Stanford, California
- +1 more
Aug 19, 2020
Pancreatic Adenocarcinoma, Resectable Pancreatic Carcinoma Trial in Portland (drug, radiation, other, procedure)
Active, not recruiting
- Pancreatic Adenocarcinoma
- Resectable Pancreatic Carcinoma
- Fluorouracil
- +6 more
-
Portland, OregonOHSU Knight Cancer Institute
Sep 2, 2021
Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma Trial in United States (bevacizumab, radiation therapy)
Completed
- Adult Giant Cell Glioblastoma
- +3 more
- bevacizumab
- radiation therapy
-
Birmingham, Alabama
- +30 more
Dec 27, 2022
SPAD in Adult Patients
Not yet recruiting
- Specific Antibody Deficiency
- Predominantly Antibody Deficiencies
- Diagnosis of SPAD using immunization with PPV23
- (no location specified)
Dec 15, 2022
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma Trial
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- +14 more
- Biospecimen Collection
- +9 more
- (no location specified)
Oct 10, 2023
Uterine Cervical Tumors Trial in Vienna (radiation, drug, other)
Recruiting
- Uterine Cervical Neoplasms
- Increased use of IC/IS technique in BT
- +8 more
-
Vienna, AustriaMedical University of Vienna
Mar 1, 2022